S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
The Safest Option in Trades! (Ad)pixel
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
Germans urged to cap heat in offices this winter to save gas
Average 126% gains – NO losers!?   (Ad)pixel
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Former Deutsche Bank Co-CEO Anshu Jain dies
High oil prices help Saudi Aramco earn $88B in first half
Average 126% gains – NO losers!?   (Ad)pixel
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
The Safest Option in Trades! (Ad)pixel
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
Germans urged to cap heat in offices this winter to save gas
Average 126% gains – NO losers!?   (Ad)pixel
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Former Deutsche Bank Co-CEO Anshu Jain dies
High oil prices help Saudi Aramco earn $88B in first half
Average 126% gains – NO losers!?   (Ad)pixel
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
The Safest Option in Trades! (Ad)pixel
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
Germans urged to cap heat in offices this winter to save gas
Average 126% gains – NO losers!?   (Ad)pixel
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Former Deutsche Bank Co-CEO Anshu Jain dies
High oil prices help Saudi Aramco earn $88B in first half
Average 126% gains – NO losers!?   (Ad)pixel
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
The Safest Option in Trades! (Ad)pixel
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
Germans urged to cap heat in offices this winter to save gas
Average 126% gains – NO losers!?   (Ad)pixel
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Former Deutsche Bank Co-CEO Anshu Jain dies
High oil prices help Saudi Aramco earn $88B in first half
Average 126% gains – NO losers!?   (Ad)pixel
NASDAQ:UG

United-Guardian - UG Stock Forecast, Price & News

$15.57
-0.72 (-4.42%)
(As of 08/12/2022 12:00 AM ET)
Add
Compare
Today's Range
$15.57
$16.50
50-Day Range
$13.67
$20.07
52-Week Range
$13.40
$26.09
Volume
8,809 shs
Average Volume
9,708 shs
Market Capitalization
N/A
P/E Ratio
19.46
Dividend Yield
4.75%
Price Target
N/A

United-Guardian MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.33% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.34mentions of United-Guardian in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.78 out of 5 stars

UG stock logo

About United-Guardian (NASDAQ:UG) Stock

United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; LUBRAJEL NATURAL consisting of natural ingredients for cosmetic use; LUBRAJEL MARINE; LUBRASIL II SB, a special formulation of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base; LUBRAJEL II XD; B-122, a powdered lubricant that is used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; KLENSOFT, a surfactant, which is used in shampoos, shower gels, makeup removers, and other cosmetic formulations; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, cleansers, and other cosmetics. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL LC and LUBRAJEL FA that are LUBRAJEL formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial product to treat infections in the urinary bladder, and localized infections in the peritoneum, as well as eye, ear, nose and throat, and sinuses. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and development primarily related to the development of cosmetic ingredients. It markets its products through marketing partners, distributors, and wholesalers. The company was founded in 1942 and is based in Hauppauge, New York.

Analysts Set New Price Targets

Separately, StockNews.com began coverage on United-Guardian in a research note on Saturday. They issued a "buy" rating on the stock.

United-Guardian Stock Performance

NASDAQ:UG traded down $0.72 during trading hours on Friday, hitting $15.57. The company's stock had a trading volume of 8,809 shares, compared to its average volume of 9,708. The stock has a fifty day simple moving average of $15.80 and a 200-day simple moving average of $18.67. United-Guardian has a twelve month low of $13.40 and a twelve month high of $26.09.

United-Guardian (NASDAQ:UG - Get Rating) last released its quarterly earnings data on Thursday, May 12th. The company reported $0.20 earnings per share for the quarter. The business had revenue of $3.89 million for the quarter. United-Guardian had a return on equity of 40.90% and a net margin of 30.50%.

Receive UG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for United-Guardian and its competitors with MarketBeat's FREE daily newsletter.

UG Stock News Headlines

United-Guardian President and CEO to retire
United-Guardian goes ex dividend tomorrow
Taking My United-Guardian Chips Off The Table
Why We Like The Returns At United-Guardian (NASDAQ:UG)
United-Guardian Reports Strong 2021 Financial Results
See More Headlines
Receive UG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for United-Guardian and its competitors with MarketBeat's FREE daily newsletter.

UG Company Calendar

Last Earnings
11/09/2017
Ex-Dividend for 6/1 Dividend
5/20/2022
Dividend Payable
6/01/2022
Today
8/14/2022
Next Earnings (Estimated)
11/09/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Toilet preparations
Sub-Industry
N/A
Sector
Medical
Employees
22
Year Founded
N/A

Profitability

Net Income
$4.66 million
Pretax Margin
38.47%

Debt

Sales & Book Value

Annual Sales
$13.93 million
Cash Flow
$1.05 per share
Book Value
$2.14 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
0.28

Key Executives

  • Mr. Kenneth H. Globus (Age 70)
    Pres, Gen. Counsel, CEO, Principal Exec. Officer & Chairman
    Comp: $405.79k
  • Ms. Donna Vigilante (Age 42)
    VP, R&D Mang. and Director of Technical Services
    Comp: $168.12k
  • Mr. Peter A. Hiltunen (Age 63)
    Sr. VP & Production Mang.
    Comp: $210.81k
  • Ms. Andrea J. Young (Age 53)
    CFO, Treasurer, Controller, Sec. & HR Mang.













UG Stock - Frequently Asked Questions

How have UG shares performed in 2022?

United-Guardian's stock was trading at $16.45 at the beginning of 2022. Since then, UG stock has decreased by 5.4% and is now trading at $15.5675.
View the best growth stocks for 2022 here
.

When is United-Guardian's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 9th 2022.
View our UG earnings forecast
.

How were United-Guardian's earnings last quarter?

United-Guardian, Inc. (NASDAQ:UG) issued its earnings results on Thursday, November, 9th. The company reported $0.24 earnings per share for the quarter. The business earned $3.18 million during the quarter. United-Guardian had a net margin of 30.50% and a trailing twelve-month return on equity of 40.90%.

How often does United-Guardian pay dividends? What is the dividend yield for United-Guardian?

United-Guardian declared a quarterly dividend on Tuesday, May 10th. Investors of record on Monday, May 23rd will be paid a dividend of $0.37 per share on Wednesday, June 1st. This represents a $1.48 dividend on an annualized basis and a dividend yield of 9.51%. The ex-dividend date of this dividend is Friday, May 20th.
Read our dividend analysis for UG
.

Is United-Guardian a good dividend stock?

United-Guardian (NASDAQ:UG) pays an annual dividend of $0.74 per share and currently has a dividend yield of 4.54%. UG has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 77.90%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for UG.

What is Kenneth H. Globus' approval rating as United-Guardian's CEO?

4 employees have rated United-Guardian Chief Executive Officer Kenneth H. Globus on Glassdoor.com. Kenneth H. Globus has an approval rating of 72% among the company's employees.

What other stocks do shareholders of United-Guardian own?

Based on aggregate information from My MarketBeat watchlists, some companies that other United-Guardian investors own include Marathon Petroleum (MPC), Pfizer (PFE), AT&T (T), Teekay LNG Partners (TGP), Verizon Communications (VZ), Walgreens Boots Alliance (WBA), Wells Fargo & Company (WFC), Continental Resources (CLR), Cinemark (CNK) and Dominion Energy (D).

What is United-Guardian's stock symbol?

United-Guardian trades on the NASDAQ under the ticker symbol "UG."

Who are United-Guardian's major shareholders?

United-Guardian's stock is owned by a number of retail and institutional investors. Top institutional investors include Renaissance Technologies LLC (4.94%), Parthenon LLC (1.15%), UBS Group AG (0.00%) and Ellsworth Advisors LLC (0.48%).
View institutional ownership trends
.

How do I buy shares of United-Guardian?

Shares of UG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is United-Guardian's stock price today?

One share of UG stock can currently be purchased for approximately $15.57.

How can I contact United-Guardian?

United-Guardian's mailing address is 230 MARCUS BOULEVARD, HAUPPAUGE NY, 11788. The official website for the company is www.u-g.com. The company can be reached via phone at (631) 273-0900 or via fax at 631-273-0858.

This page (NASDAQ:UG) was last updated on 8/14/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.